Literature DB >> 7524531

Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action.

B E Bierer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7524531

Source DB:  PubMed          Journal:  Chem Immunol        ISSN： 0079-6034


× No keyword cloud information.
  7 in total

1.  Calcineurin-dependent nuclear translocation of a murine transcription factor NFATx: molecular cloning and functional characterization.

Authors:  J Liu; N Koyano-Nakagawa; Y Amasaki; F Saito-Ohara; T Ikeuchi; S Imai; T Takano; N Arai; T Yokota; K Arai
Journal:  Mol Biol Cell       Date:  1997-01       Impact factor: 4.138

Review 2.  Cyclophilin A: promising new target in cardiovascular therapy.

Authors:  Kimio Satoh; Hiroaki Shimokawa; Bradford C Berk
Journal:  Circ J       Date:  2010-10-15       Impact factor: 2.993

3.  Identification and characterization of an immunophilin expressed during the clonal expansion phase of adipocyte differentiation.

Authors:  W C Yeh; T K Li; B E Bierer; S L McKnight
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

4.  Rapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells.

Authors:  W C Yeh; B E Bierer; S L McKnight
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

Review 5.  Oxidative stress and vascular smooth muscle cell growth: a mechanistic linkage by cyclophilin A.

Authors:  Kimio Satoh; Patrizia Nigro; Bradford C Berk
Journal:  Antioxid Redox Signal       Date:  2010-03-01       Impact factor: 8.401

6.  A calcium-initiated signaling pathway propagated through calcineurin and cAMP response element-binding protein activates proenkephalin gene transcription after depolarization.

Authors:  Sung Ho Hahm; Yun Chen; Charles Vinson; Lee E Eiden
Journal:  Mol Pharmacol       Date:  2003-12       Impact factor: 4.436

7.  Distinct T cell receptor signaling requirements for perforin- or FasL-mediated cytotoxicity.

Authors:  M T Esser; B Krishnamurthy; V L Braciale
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.